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Abstract
Background: Trypanosoma cruzi, a kinetoplastid protozoan parasite that causes Chagas disease,
infects approximately 15 million people in Central and South America. In contrast to the substantial
in silico studies of the T. cruzi genome, transcriptome, and proteome, only a few genes have been
experimentally characterized and validated, mainly due to the lack of facile methods for gene
manipulation needed for reverse genetic studies. Current strategies for gene disruption in T. cruzi
are tedious and time consuming. In this study we have compared the conventional multi-step
cloning technique with two knockout strategies that have been proven to work in other organisms,
one-step-PCR- and Multisite Gateway-based systems.
Results: While the one-step-PCR strategy was found to be the fastest method for production of
knockout constructs, it does not efficiently target genes of interest using gene-specific sequences
of less than 80 nucleotides. Alternatively, the Multisite Gateway based approach is less time-
consuming than conventional methods and is able to efficiently and reproducibly delete target
genes.
Conclusion: Using the Multisite Gateway strategy, we have rapidly produced constructs that
successfully produce specific gene deletions in epimastigotes of T. cruzi. This methodology should
greatly facilitate reverse genetic studies in T. cruzi.
Background
Trypanosoma cruzi is a protozoan parasite and the etiolog-
ical agent of Chagas disease in humans, also known as
American trypanosomiasis. T. cruzi infects over 100 spe-
cies of mammalian hosts and is the leading cause of infec-
tion-induced heart failure in Latin America [1,2]. In 2006,
approximately 12,500 deaths have been reported as a
result of the clinical complications of T. cruzi-induced
heart disease and the lack of effective treatment [3].
T. cruzi has four morphologically and physiologically dis-
tinct stages. The bloodstream trypomastigotes and intrac-
ellular amastigotes stages of parasites are in the
mammalian host, whereas epimastigotes and metacyclic
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loid genome of T. cruzi contains approximately 40 chro-
mosomes encoding a predicted set of 22,570 proteins, of
which at least 12,570 represent allelic pairs [5]. Allelic
copies of genes in the hybrid CL Brener genome may vary
in sequence by as much as 1.5%, and trisomy has also
been suggested in the case of some chromosomes [6,7].
Putative functions could be assigned to 50.8% of the pre-
dicted protein-coding genes on the basis of significant
similarity to previously characterized proteins or known
functional domains [5].
In contrast to the substantial in silico studies of the T. cruzi
genome, only 10 genes have been experimentally charac-
terized by reverse genetics in T. cruzi [8-18]. These genes
were all disrupted through homologous recombination,
using a DNA cassette that has a drug selectable marker
flanked by the coding sequence or the untranslated
regions (UTRs) of the target gene. Although effective, this
conventional gene knockout approach not only requires
identification of multiple compatible restriction sites for
ligation reactions and for vector linearization, it also
involves multiple restriction digestions, ligations and
cloning steps that make the process cumbersome and
time-consuming [19]. Given that RNA interference has, to
date, failed to function in T. cruzi [20] (in contrast to the
situation in the African trypanosomes [21]), a simplified
strategy to knockout genes in T. cruzi would vastly
improve the characterization of the multitude of genes
encoding proteins without confirmed or even putative
functions.
In this study, we sought to develop a simpler method for
the deletion of T. cruzi genes. We compared the conven-
tional multi-step knockout technique with two knockout
strategies that have been proven to work in other organ-
isms, one-step-PCR- and Multisite Gateway (MS/GW) -
based systems. We attempted to knockout the dihydro-
folate reductase-thymidylate synthase (dhfr-ts) using all
three techniques, and enoyl-CoA hydratase (ech) genes
using the two alternative approaches. Our results show
that gene-specific sequences of 78 nucleotides used in
one-step-PCR strategy are not sufficient to guarantee
homologous recombination in T. cruzi. However, the MS/
GW-based approach is able to efficiently disrupt target
genes. In addition, using the MS/GW strategy, generation
of knockout constructs can be completed in as few as 5
days. The results of this study will provide a powerful new
tool for reverse genetic studies of T. cruzi.
Results
dhfr-ts gene is disrupted using a conventional KO 
construct
The dhfr-ts gene is annotated as two identical alleles in the
diploid CL Brener reference strain and codes for dihydro-
folate reductase thymidylate syntase [5]. In most organ-
isms these two enzyme activities are present on separate
monofunctional enzymes. In contrast, in T. cruzi both
enzymes are on the same polypeptide chain, with the
DHFR domain at the amino terminus and the TS domain
at the carboxy terminus [22,23]. Since these enzymes cat-
alyze consecutive reactions in the de novo synthesis of 2'-
deoxythymidylate (dTMP), they have been used as targets
for chemotherapy, as inhibition of either enzyme disrupts
the dTMP cycle and results in thymidine auxotrophy [24-
26].
G418 (geneticin)-resistant parasites were obtained after
transfection of the recombination fragment excised from
the plasmid pBSdh1f8Neo (Additional file 1: Figure S1)
into the Tulahuen strain of T. cruzi. We included a 280 bp
1F8 fraction in the construct so as to provide a trans-splic-
ing acceptor site and a putative polyadenylation signal to
the drug resistance gene [27]. Figure 1A shows the
expected genomic loci of dhfr-ts and 1f8Neo in dhfr-ts+/-/
Neo parasites. As expected no amplification of the 1f8Neo
was observed in Tulahuen WT (wild type) parasites as
shown by PCR with primers N1-N2 (Figure 1B). PCR
using primers in the flanking genes corroborates the cor-
rect insertion of 1f8Neo gene in dhfr-ts+/- parasite's
genome. When using N3-R1, N3-R2 and N3-R3 combina-
tions, bands of 1.9, 2.2 and 2.65 kb respectively, were
observed, providing further confirmation that the neomy-
cin phosphotransferase gene (Neo) had been inserted in
the correct locus (Figure 1C). The insertion in the dhfr-ts
locus was also confirmed by Southern Blot analysis with
gDNA from cloned dhfr-ts+/- and WT parasites digested
with SalI and probed with dhfr-ts (Figure 1D). When
digested with enzymes SalI and probed with dhfr-ts CDS
we observe a band of 3.2 kb in wild type parasites while
mutants have a 1092 bp insertion corresponding to the
1f8Neo cassette interrupting the dhfr-ts CDS, resulting in
an extra 4.4 kb band in the mutants.
dhfr-ts gene is replaced using a MS/GW construct
Since we were able to obtain dhfr-ts+/- parasites we con-
cluded that this gene would be a good candidate to evalu-
ate the one-step-PCR and Multisite Gateway-based
systems for gene knockout constructs in T. cruzi. In the
MS/GW recombination fragments, the flanking regions of
the gene were used as arms for recombination event, in
contrast with the method in Figure 1 where the coding
sequence of the gene was used for homologous recombi-
nation.
Drug resistant lines produced by the transfection of Tula-
huen strain epimastigotes with a recombination fragment
obtained from pDEST/dhfr-ts_1F8Hyg plasmid (Addi-
tional file 2: Figure S2) were cloned and analyzed by PCR
and Southern Blot. Figure 2A shows the expected genomicPage 2 of 10
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parasites; the results of PCR analysis (Figure 2B) confirm
the correct insertion of 1f8Hyg replacing one allele of the
dhfr-ts gene (Additional file 3). Southern Blot analysis also
showed correct insertion of the 1f8Hyg cassette replacing
one copy of the dhfr-ts gene in the genome. The expected
1312 bp band was observed in BsrGI digested DNA from
dhfr-ts+/- cloned parasites and probed with Hyg (hygromy-
cin resistance gene) CDS but not in the WT parasites (Fig-
ure 2C).
Consecutive ech1 and ech2 genes are simultaneously 
replaced by constructs generated based on MS/GW system
T. cruzi ech1 and ech2 are tandemly arranged genes (Figure
3A) with a nucleotide sequence identity of 67%. Both
genes encode putative enoyl-CoA hydratase/isomerase
(ECH) family proteins, which catalyze the second step in
the beta-oxidation pathway of fatty acid metabolism.
Analysis of the T. cruzi proteome suggested that enzymes
in the fatty acid oxidation pathway, including ECH, are
preferentially expressed in amastigotes [28]. Therefore, we
hypothesized that we would be able to knockout both
ech1 and ech2 genes in epimastigotes. The ech locus also
provides an opportunity to test whether or not the MS/
GW approach can be used to produce knockouts of mul-
tiple genes that are physically linked in the genome.
In T. cruzi, transcript stability and protein translation is
largely controlled by 3'UTR and intergenic regions
[29,30]. The intergenic region of a constitutively expressed
gene, gapdh, gives consistently high levels of stable RNA in
different constructs and in different life cycle stages [31].
Hence, we included the 3' UTR of gapdh in our constructs,
to ensure the expression of the inserted drug resistant
Disruption of dhfr-ts using a conventional KO construct pBSdh1f8NeoFigure 1
Disruption of dhfr-ts using a conventional KO construct pBSdh1f8Neo. A) Diagram of the expected genomic loci of 
dhfr-ts and 1f8Neo in dhfr-ts+/-/Neo parasites. B) PCR analysis with Neo specific primers of WT Tulahuen and both uncloned and 
selected clones of dhfr-ts+/-/Neo parasites. C) PCR analysis with gDNA from selected clones of dhfr-ts+/-/Neo and WT Tulahuen 
parasites confirming the expected gene disruption of one allele of the dhfr-ts gene by 1f8Neo. D) Southern Blot analysis of WT 
Tulahuen and two dhfr-ts+/-/Neo clones digested with SalI and probed with dhfr-ts probe. Diagram not to scale. Numbers are 
sizes (bp) of expected products.Page 3 of 10
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fragment from pDEST/ech-Hyg-GAPDH (Additional file 4:
Figure S3A) resulted in parasite lines that were resistant to
Hyg selection. Figure 3A shows the expected genomic loci
of ech and Hyg-GAPDH-IR in the genome of ech+/-/Hyg
parasites. PCR analysis with the genomic DNA from the
drug resistant parasites and WT CL confirmed the
expected gene replacement of ech1 and ech2 genes by Hyg-
GAPDH-IR (Figure 3B); no products were obtained when
using WT CL gDNA as the template with primer combina-
tions f2 and D, f2 and F, C and r2, and E and r2, whereas
products of the expected sizes, 1759 bp, 2178 bp, 2696 bp
and 2889 bp, respectively, were observed with gDNA from
ech+/-/Hyg as the template. Southern blot analysis of EcoR
I digested gDNA using the ech1 gene as a probe (Figure 3A
and 3C right panel) showed a 4880 bp band correspond-
ing to the replaced allelic copy of both ech genes was
undetected in ech+/-/Hyg, whereas the 3490 bp and 1365
bp bands corresponding to the second allele were
retained. In addition, a 2988 bp band and a 1478 bp band
corresponding to the inserted Hyg-GAPDH-IR were
observed in BanI digested gDNA of only the ech+/-/Hyg,
but not that of WT CL (Figure 3A and 3C left panel). Taken
together, these results confirmed that one copy of each of
the tandem ech1 and ech2 genes was replaced by the MS/
GW Hyg-GAPDH-IR knockout cassette.
Similarly, using linearized DNA from pDEST/ech_Neo-
GAPDH (Additional file 4: Figure S3B), we generated ech+/
-/Neo parasites with one copy of both ech1 and ech2 gene
replaced by Neo-GAPDH-3'UTR knockout cassette (Figure
4A). This result is confirmed by both PCR amplification
(Figure 4B) of gDNA of the drug resistant parasites, as PCR
with primer combinations f2 and B, and f2 and H gener-
ated 1494 bp and 1949 bp bands respectively only in drug
resistant parasites. Southern blot hybridization also
Replacement of dhfr-ts gene with a MS/GW construct pDEST/dhfr-ts_1F8HygFigure 2
Replacement of dhfr-ts gene with a MS/GW construct pDEST/dhfr-ts_1F8Hyg. A) Schematic of the expected 
genomic loci of dhfr-ts and 1f8Hyg in dhfr-ts+/-/Hyg parasites. B) PCR analysis with gDNA from cloned drug resistant parasites 
and WT Tulahuen parasites confirm the expected gene deletion of one allele of the dhfr-ts gene and correct insertion of 
1f8Hyg. Primer H1 plus the R1, R2 or R3 downstream primers, yield the expected products of 1.8, 2.0 and 2.3 kb, respectively 
and the combination of H5 plus upstream primers F3, F2 and F1 give the predicted bands of 2.1, 2.4 and 2.8 kb for respectively. 
See additional file 3: Table S5 for nucleotide sequences of primers. C) Genomic DNA Southern blot analysis of a dhfr-ts+/-/Hyg 
Tulahuen clone. gDNA digested with BsrGI and hybridized with labeled Hyg CDS probe. Diagram not to scale. Numbers are 
sizes (bp) of expected products.Page 4 of 10
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sites (Figure 4C).
One-step-PCR knockout strategy fails to delete dhfr-ts 
and ech genes
Since we demonstrated that at least one allele of the dhfr-
ts can be deleted using the MS/GW based system, we next
tested if this gene can be deleted using the one-step-PCR
strategy. Transfection and selection of parasites with the
knockout cassette LP-dhfr-ts-Neo failed to yield drug
resistant parasites, despite 4 independent attempts. As
there are 78 nts of the CDS of dhfr-ts gene in both forward
long primers used to produce LP-dhfr-ts-Neo, the drug
selectable markers were to be expressed as a fusion pro-
tein, with 26 amino acids of the start of dhfr-ts gene fused
at the N terminal. It is possible that the knockout parasites
were not obtained because the drug selectable marker has
reduced enzyme activity when expressed as a fusion pro-
tein. To exclude this possibility, we constructed LP-dhfr-ts-
UTR-Neo to completely delete the entire dhfr-ts sequence.
This construct has 78 nts of the UTR of dhfr-ts gene instead
of the CDS, providing production of neomycin phospho-
transferase as a non-fusion protein. However, as with the
previous construction, no resistant parasites could be
obtained despite 4 independent electroporations. Further-
more, one-step-PCR strategy also failed to delete the ech1
and ech2 genes despite 5 independent transfection and
selection attempts. Therefore, the constructs generated
Simultaneous replacement of consecutive ech1 and ech2 genes by a MS/GW construct pDEST/ech-Hyg-GAPDHFig re 3
Simultaneous replacement of consecutive ech1 and ech2 genes by a MS/GW construct pDEST/ech-Hyg-
GAPDH. A) Diagram of ech1, ech2 and Hyg-GAPDH-IR genomic loci in WT and ech+/-/Hyg parasites. B) PCR genotyping analysis 
of: no template control (water); ech+/-/Hyg (ech+/-) and WT CL (WT). See additional file 3: Table S5 for nucleotide sequences of 
primers. C) Southern blot analysis of two clones (2 and 4) of ech+/-/Hyg. Left panel, gDNA digested with BanI and hybridized 
with Hyg CDS; right panel, gDNA digested with EcoRI and hybridized with labeled ech1 CDS. Diagrams not to scale. Numbers 
are sizes (bp) of expected products.Page 5 of 10
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UTR specific sequence are likely to be insufficient for
homologous recombination in T. cruzi.
Discussion
Experimental characterization of gene functions in
trypanosomatids has relied heavily on reverse genetic
approaches and has been facilitated by the development
and optimization of gene manipulation strategies and
transfection protocols [30]. In contrast to the robust and
extensive techniques for genetic manipulation docu-
mented in Trypanosoma brucei and Leishmania, the vali-
dated techniques and record of success for T. cruzi is much
less extensive. A goal of this study was to validate gene KO
strategies for T. cruzi which might facilitate research on
this important cause of human disease.
Toward that end, we have compared a conventional
multi-step cloning technique with two knockout strate-
gies that have been proven to target gene deletion in other
organisms, one-step-PCR and MultiSite Gateway. The
appeal of the one-step-PCR- strategy is the speed with
which constructs can be produced. However, the attempts
to knockout either ech or dhfr-ts genes in T. cruzi using this
approach were unsuccessful, presumably because the 78
nucleotide-gene-specific regions used in our constructs
were insufficient for homologous recombination in T.
cruzi. This result is perhaps not surprising as studies in
Leishmania [32] demonstrated that at least 150 nucle-
otides are needed to guide homologous recombination.
However, a recombination rate of 4 × 10-4 was obtained
with as short as 42 nucleotides homology in T. brucei [33].
Because of the considerable expense of oligos of >100 bp,
we did not investigate the minimum length needed for
consistent recombination in T. cruzi, believing such an
approach to be impractical for economical, high-effi-
ciency gene knockouts.
The MultiSite Gateway-based approach, although not as
simple as the one-step-PCR strategy, is far less time-con-
suming than the standard conventional methods. In par-
ticular, extensive restriction mapping, digestion and
ligation steps are not needed at all with the MS/GW
approach [34]. pDONR vectors containing drug resistance
genes can be generated once and then repeatedly re-used
for production of knockout constructs for different genes,
further increasing the efficiency of the process. Once
regions flanking the genes of interest are obtained from
the att- PCR amplifications, the knockout DNA constructs
can be generated within as few as five days (Figure 5). The
BP and LR reactions are robust and have very high success
rates; typically, at least 90% colonies screened from our
BP and LR reactions are positive. Using the MS/GW
knockout constructs, we successfully obtained dhfr-ts+/-
and ech+/- parasites in two different T. cruzi strains. In on-
going work, we have used MS/GW constructs to success-
fully produce single as well as double KO lines for more
than 10 other genes, ranging in size from 828 to 2730
nucleotides and up to 3 copies (using additional drug
resistance markers). Thus the MS/GW approach appears
to be amenable to use as part of a higher throughput gene
knockout project.
Overall, the results described here identify the Multisite
Gateway (MS/GW) -based system as an efficient tool to
create knockout construction for deletion of genes in T.
cruzi and should help accelerate the functional analysis of
a wider array of genes in this important agent of disease.
Conclusion
This study documents the development of a Multisite
Gateway based method for efficient gene knockout in T.
cruzi. Further, we demonstrate that long-primer-based KO
constructs with <80 nucleotides of homologous gene
sequences are insufficient for consistent homologous
recombination in T. cruzi. The increase in efficiency of
gene knockout constructs should facilitate increased
throughput for the identification of gene function in T.
cruzi using reverse genetics.
Methods
Culture, transfection and cloning of T. cruzi
CL and Tulahuen lines of T. cruzi epimastigotes were cul-
tured at 26°C in supplemented liver digest-neutralized
Simultaneous replacement of consecutive ech1 and ech2 genes by anoth r MS/GW construct pDEST/ech_Neo-GAPDHFig re 4
Simultaneous replacement of consecutive ech1 and 
ech2 genes by another MS/GW construct pDEST/
ech_Neo-GAPDH. A) Diagram of ech1, ech2 and Neo-
GAPDH 3'UTR genomic loci in ech+/-/Neo parasites. B) PCR 
genotyping analysis of: no template control (water); ech+/-/
Neo (ech+/-) and WT CL (WT). See additional file 3: Table S5 
for nucleotide sequences of primers. C) Southern blot analy-
sis of WT CL (WT) and ech+/-/Neo (ech+/-) digested with 
EcoRI and hybridized with Neo CDS. Diagram not to scale. 
Numbers are sizes (bp) of expected products.Page 6 of 10
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total of 1 × 107 early-log epimastigotes were centrifuged at
1,620 g for 15 min and resuspended in 100 μl room tem-
perature Human T Cell Nucleofector™ Solution (Amaxa
AG, Cologne, Germany). The resuspended parasites were
then mixed with 3–10 μg DNA (8–10 μg DNA for con-
structs generated using the conventional and MS/GW
strategy; 3–10 μg DNA for constructs generated through
one-step-PCR) in a total volume of 5–10 μl and electropo-
rated using program "U-33" in an AMAXA Nucleofector
Device. This protocol generally yields 6–13% yellow fluo-
rescent protein (YFP) positive parasites 24 hrs after trans-
fection using 10 μg of a YFP-containing control plasmid.
The electroporated parasites are cultured in 25 cm2 cell
culture flasks (Corning Incorporated, Lowell, MA, USA)
with 10 ml LDNT medium; 250 μg/ml G418 (for trans-
fectants with neomycin phosphotransferase gene-contain-
ing cassette) and/or 600 μg/ml Hyg (Hygromycin B, for
transfectants with hygromycin reisitance gene-containing
cassette) was added at 24 hrs post-transfection. Parasites
were considered fully selected when parasites transfected
with no DNA were dead, generally at 4–5 weeks post-
transfection. For single-cell cloning, drug selected lines
were deposited into a 96-well plate to a density of 1 cell/
well using a MoFlow (Dako-Cytomation, Denmark) cell
sorter and cultured in 250 μl LDNT supplemented with
G418 or Hyg. Each population from an individual well
was considered an individual clone.
Timeline for constructing a KO plasmids using MS/GW strategyF gure 5
Timeline for constructing a KO plasmids using MS/GW strategy. The Multisite Gateway based method consists of 
three steps: 1) PCR with attB-containing primers to amplify 5' and 3' UTR from genomic DNA; 2) BP recombination of each 
PCR products with specific donor vectors to generate entry clones containing the UTRs; 3) LR recombination of the two entry 
clones made in step 2 and a third entry clone containing Neo/Hyg to create the final construct. (Kan, kanamycin-resistance 
gene; Amp, ampicillin-resistance gene; Ori, Origin of replication).Page 7 of 10
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conventional strategy
The complete coding sequence of 1566 bp of the dhfr-ts
gene was amplified by PCR from genomic DNA (gDNA)
of the WT Tulahuen strain using AmpliTaq Gold® DNA
Polymerase (Roche) and primers DH5_f and DH6_r
(Additional file 5: Table S1). The PCR product was gel
purified with QIAquick Gel Extraction Kit (Qiagen, Valen-
cia, CA, USA), treated with T4 DNA Polymerase (BioLabs)
to generate blunt ends and cloned into the KpnI-digested,
T4 DNA Polymerase (BioLabs) treated and dephosphor-
ylated pBlueScript SKII + (Stratagene). Then the dhfr-ts
coding region was disrupted by inserting into the PshAI
restriction site of the dhfr-ts gene the neomycin phospho-
transferase gene which have been generated by digestion
with NotI/StuI of pBSSK-neo1f8 plasmid [27]. The result-
ing recombination vector were sequenced and designated
as pBSdh1f8Neo (Additional file 1: Figure S1) containing
the Neo CDS plus the trans-splicing 1f8 region, as well as
1016 bp and 550 bp of the 5' and 3'dhfr-ts coding regions.
The final plasmid was digested with restriction enzyme
KpnI to liberate the knockout DNA cassette, gel eluted,
ethanol precipitated and resuspended in water to a final
concentration of 1–2 μg/μl.
Construction of knockout DNA cassettes based on MS/GW 
strategy
All plasmids were constructed based on MS/GW system
using commercially available MultiSite Gateway Three-
Fragment Vector Construction kit (Invitrogen, Carlsbad,
CA, USA), which includes all the Entry vectors and Desti-
nation vectors used in this study (Figure 5). In the Gate-
way system, the "BP" reaction is a recombination reaction
between attB and attP sites in the PCR fragment and
Donor vectors, resulting in Entry clones contains the gene
of interest flanked by attL sites. "LR" reactions allow
recombination between attL and attR sites of a Destina-
tion vector to yield an expression clone.
pDEST/dhfr-ts_1F8Hyg
In order to construct the pDEST/dhfr-ts_1F8Hyg plasmid,
1.0-kb 5' flanking sequence of dhfr-ts was amplified from
gDNA of the WT CL strain using primers
attB4_5'UTR_dhfr_f and attB1_5'UTR_dhfr_r (Additional
file 6: Table S2) and Platinum® PCR SuperMix (Invitro-
gen), gel purified with QIAquick Gel Extraction Kit (Qia-
gen, Valencia, CA, USA) and cloned into the Entry vector
pDONR™P4-P1R through a BP reaction using the BP
Clonase II Enzyme Mix (Invitrogen), resulting in the Entry
clone pDONR_5'UTR_dhfr. Similarly, 1.0-kb 3' flanking
sequence of dhfr-ts was amplified using primers
attB2_3'UTR_dhfr_f and attB3_3'UTR_dhfr_r (Additional
file 6: Table S2) and cloned into pDONR™P2R-P3 to gen-
erate pDONR_3'UTR_dhfr. Using plasmid pBSSK-hyg1f8
[27] as a template, the Hyg and its upstream 1f8 region
was amplified with primers attB1_1F8_f and
attB2_1F8Hyg_r (Additional file 6: Table S2) and cloned
into Entry vector pDONR™221. The three Entry clones
were then mixed with a Destination vector pDEST™R4-R3
in an LR reaction using the LR Clonase II Plus Enzyme Mix
(Invitrogen) to generate a final plasmid pDEST/dhfr-
ts_1F8Hyg (Additional file 2: Figure S2). The knockout
DNA cassette was liberated from the plasmid backbone
with AlwNI and PvuI enzymes, and purified as above.
pDEST/ech_Neo-GAPDH and pDEST/ech_Hyg-GAPDH
Trypanosoma cruzi ech1 and ech2 are tandemly arranged
genes. To construct the pDEST/ech_Hyg-GAPDH plasmid,
1.0-kb 5' sequence of ech2 was amplified with primers
attB4_ech5'UTR_f and attB1_ech5'UTR_r (Additional file
6: Table S2), gel purified and cloned into the Entry clone
pDONR-ech5'UTR. Similarly, 1.0-kb 3' sequence of ech1
was amplified with primers attB2_ech3'UTR_f and
attB3_ech3'UTR_r (Additional file 6: Table S2) and cloned
into pDONR™P2R-P3 to generate pDONR-ech3'UTR. Hyg
and the downstream intergenic region of GAPDH (glycer-
aldehyde-3-phosphate dehydrogenase) (GAPDH-IR) was
amplified from plasmid pTEX-Hyg.mcs [36] using prim-
ers attB1_Hyg_f and attB2_Hyg_r (Additional file 6: Table
S2) and cloned into Entry vector pDONR™221. The three
Entry clones were then mixed with a Destination vector
pDEST™R4-R3 to generate pDEST/ech_Hyg-GAPDH
(Additional file 4: Figure S3A) through a LR reaction. The
final plasmid was digested with restriction enzymes PvuII
and PciI and purified as above.
Similarly, to construct pDEST/ech_Neo-GAPDH (Addi-
tional file 4: Figure S3B), Neo and 3'UTR of GAPDH
(GAPDH 3'UTR) was amplified from plasmid pTrex-YFP
(modified from the backbone of pTrex [37]) with primers
attB1_Neo_f and attB2_Neo_r (Additional file 6: Table
S2) and cloned into Entry vector pDONR™221. The final
plasmid was digested with restriction enzymes PvuI and
PciI and purified as above.
Construction of knockout DNA cassettes via one-step-PCR
For the constructs for deletion of the dhfr-ts gene using
one-step-PCR, Neo and Hyg was amplified with primers
LP_dhfr_Neo_f and LP_dhfr_Neo_r, and LP_dhfr_Hyg_f
and LP_dhfr_Hyg_r (Additional file 7: Table S3) from
plasmids pTrex-YFP and pTEX-Hyg.mcs respectively. In
both cases, forward primers and reverse primers corre-
sponded to the 78 bp downstream of the start codon of
the dhfr-ts gene and reverse 78 bp upstream of the stop
codon of the gene, respectively.Page 8 of 10
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UTR_Neo_r, (Additional file 7: Table S3) were also used
to amplify Neo from pTrex-YFP. In this case, LP_dhfr-
UTR_Neo_f included 78 bp upstream of the start codon of
the dhfr-ts gene whereas LP_dhfr-UTR_Neo_r bears 78 bp
downstream of the stop codon.
Likewise, primers LP_ech_Neo_f and LP_ech_Neo_r
(Additional file 7: Table S3) were designed to amplify the
final construction for deletion of the ech genes as well as
primers LP_ech_Hyg_f and LP_ech_Hyg_r (Additional file
7: Table S3). PCR reactions were carried out as follows:
initial denaturation at 94°C for 3 min followed by 30
cycles of: 98°C for 20s; 55°C for 30s; and 72°C for 2 min
followed by 72°C for 10 min using Gradient Master Ther-
mocycler (Eppendorf, Westbury, NY, USA). Products were
collected and purified with QIAquick PCR Purification
Kit. The eluted DNA was further ethanol precipitated and
resuspended to 0.2–1 μg/μl.
Southern blot
For Southern blot analysis, gDNA from different clones
and strains was purified using Wizard Genomic DNA
Purification Kit (Promega Corporation, Madison, WI,
USA). The DNA was digested and separated by 0.7% aga-
rose gel electrophoresis, and the gels blotted onto nylon
membranes (Hybond-N 0.45-mm-pore-size filters; Amer-
sham Life Science) using standard methods [38]. For
probe generation, a 1030 bp DNA (Hyg) was amplified
using primers Hyg_f and Hyg_r (Additional file 8: Table
S4) from plasmid pTEX-Hyg.mcs. For the Neo probe, a
795 bp DNA fragment was amplified from plasmid
pBSSK-neo1f8 using primers Neo_f and Neo_r (Addi-
tional file 8: Table S4). ech1 gene were amplified using
primers ech1_pb_f and ech1_pb_r (Additional file 8:
Table S4) from gDNA of WT CL, while dhfr-ts gene was
amplified from gDNA of WT Tulahuen using primers
DH5_f and DH6_r (Additional file 5: Table S1). The PCR
products were purified as above. Labeling of the probe
and DNA hybridization were performed according to the
protocol supplied with the PCR-DIG DNA-labeling and
detection kit (Roche Applied Science, Indianapolis, IN,
USA).
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